Zealand Pharma A/S
KV1.3 BLOCKERS
Last updated:
Abstract:
The present invention provides novel blockers of the potassium channel Kv1.3, polynucleotides encoding them, and methods of making and using them.
Status:
Application
Type:
Utility
Filling date:
24 Feb 2022
Issue date:
11 Aug 2022